Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization?
Adolescent
Adult
Aged
Aged, 80 and over
Angiography, Digital Subtraction
Central Nervous System Vascular Malformations
/ diagnostic imaging
Cerebral Angiography
/ methods
Dimethyl Sulfoxide
Embolization, Therapeutic
/ methods
Endovascular Procedures
Female
Follow-Up Studies
Humans
Magnetic Resonance Angiography
Male
Middle Aged
Polyvinyls
Prospective Studies
Recurrence
Treatment Outcome
Young Adult
Onyx
arteriovenous fistula
embolization
interventional neurosurgery
recurrence
vascular disorders
Journal
Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357
Informations de publication
Date de publication:
01 Jan 2022
01 Jan 2022
Historique:
received:
19
10
2020
accepted:
02
12
2020
pubmed:
26
6
2021
medline:
21
1
2022
entrez:
25
6
2021
Statut:
epublish
Résumé
The natural course of dural arteriovenous fistulas (DAVFs) is unfavorable. Transarterial embolization with Onyx is currently the therapeutic method of choice, although the long-term stability of Onyx has been questioned. The literature reports a significant difference in the recurrence rate after complete DAVF occlusion and lacks larger series with long-term follow-up. The authors present the largest series to date with a long-term follow-up to determine the stability of Onyx, prospectively comparing magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) as follow-up diagnostic methods. Demographics, clinical symptomatology, length of follow-up, diagnostic methods, and angiographic findings of DAVFs were recorded and retrospectively evaluated in 112 patients. A prospective group of 15 patients with more than 5 years of follow-up after complete DAVF occlusion was established. All 15 patients in the prospective group underwent a clinical examination and MRA; 10 of these patients also underwent DSA. The recurrences and the correlation between the two diagnostic methods were evaluated. Among the 112 patients, 71 were men and 41 were women, with an average age of 60 years. Intracranial hemorrhage (40%) was the most common clinical presentation of DAVF. At the last follow-up, 73% of the patients experienced clinical improvement, 21% remained unchanged, and 6% worsened. Overall, 87.5% of the DAVFs were occluded entirely with endovascular treatment, and 93% of the DAVFs were classified as cured at the last follow-up (i.e., completely embolized DAVFs and DAVFs that thrombosed spontaneously or after Gamma Knife surgery). Two recurrences of DAVFs were recorded in the entire series. Both were first diagnosed by MRA and confirmed with DSA. The mean follow-up was 27.7 months. In the prospective group, a small asymptomatic recurrence was diagnosed. The mean follow-up of the prospective group was 96 months. Onyx is a stable embolic material, although recurrence of seemingly completely occluded DAVFs may develop because of postembolization hemodynamic changes that accentuate primarily graphically absent residual fistula. These residuals can be diagnosed with MRA at follow-up. The authors' data suggest that MRA could be sufficient as the follow-up diagnostic method after complete DAVF occlusion with Onyx. However, larger prospective studies on this topic are needed.
Identifiants
pubmed: 34171837
doi: 10.3171/2020.12.JNS203811
doi:
Substances chimiques
Onyx copolymer
0
Polyvinyls
0
Dimethyl Sulfoxide
YOW8V9698H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM